newsfilter
← Latest News
GlobeNewswire·

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

BMEA
  • Biomea Fusion granted one new employee non-qualified stock option for 7,500 shares on November 26, 2025.
  • The shares will vest 1/16 quarterly over four years subject to continued employment.
  • The award was made under the 2023 Inducement Equity Plan to induce the employee to join the company per Nasdaq Listing Rule 5635(c)(4).
  • The Plan was adopted by the board on November 17, 2023.
  • Biomea is a clinical-stage company developing oral small molecules icovamenib & BMF-650 for diabetes & obesity.